Updated February 27 at 4:27pm
Biotechnology
45 results total, viewing 21 - 30
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported. more
Nearly halfway through fiscal year 2014, National Institutes of Health grants to Rhode Island institutions are well short of the pace set in the previous year, according to figures on the NIH’s website. more
Taking the next steps in centralizing and building on its research capabilities, Lifespan announced Monday the creation of the Clinical Research Center, to be based at the health care conglomerate’s Coro Building in Providence’s Knowledge District, as well as at The Miriam Hospital in the city’s East Side. more
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
MassChallenge, a startup accelerator program, awarded $1.75 million at its annual startup awards ceremony Wednesday, the Boston Business Journal reported. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »